We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Based on President Bush’s State of the Union address, the debate over how to improve the healthcare system comes down to the administration’s call for tax deductions and state grant programs versus Democrats’ plans to give the government the authority to negotiate Medicare prices.
Republican members of the House and Senate are proposing a federal commission to study entitlement spending, including Medicare and Medicaid, with an eye toward developing ways to lower the costs of these programs.
Republican members of the House and Senate are proposing a federal commission to study entitlement spending, including Medicare and Medicaid, with an eye toward developing ways to lower the costs of these programs.
Alex Azar, HHS’ deputy secretary, is resigning, leaving a void in the agency’s efforts to continue implementation of the Part D prescription drug plan, sources say.
The Democrats’ plan to give the federal government the authority to negotiate for lower Medicare prices has taken another step forward as the House passed H.R.4 Jan. 12 by a vote of 255–170.
Novartis’ fourth quarter net profit for 2006 rose 23 percent with strong showings from hypertension drug Diovan and leukemia drug Gleevec, the company announced.
The Democrats’ plan to give the federal government the authority to negotiate for lower Medicare prices has taken another step forward as the House passed H.R.4 Jan. 12 by a vote of 255–170.
A bipartisan group of House members is continuing to push for passage of a bill allowing the government to negotiate drug prices for Medicare Part D, even while the government agency in charge of the program said the bill will not save money.
A bipartisan proposal to give the federal government the authority to negotiate Medicare Part D drug prices has taken a major step forward as one of the key opponents to the plan has changed his position.
A bipartisan proposal to give the federal government the authority to negotiate Medicare Part D drug prices has taken a major step forward as one of the key opponents to the plan has changed his position.